Mon 24 Aug 2026 International edition
Precision Medicine Unlocking the Blueprint of Human Sight: Johns Hopkins Researchers Reveal How Prenatal Biology Engineers Our Sharpest Vision
Clinical Trials & Research Neurocrine begins Phase I trial of NBIP-‘1968 triple agonist for obesity
Oncology & Cancer Research Breaking a 15-Year Microbiological Mystery: How a Common Gut Toxin Hijacks Colon Cells—and How Scientists Stopped It
Hematology & Blood Research Executive Overview
Bio-Research & Life Sciences Challenging Oceanography’s Oldest Dogmas: How Ancient Sediments Rewrite the Rules of Global Climate Circulation
Microbiology & Infectious Diseases Nature’s Ultimate Illusionist: Newly Discovered Ecuadorian Spider Mimics the Very Parasite That Destroys Its Own Kind
Oncology & Cancer Research Decoding the Tumor Microenvironment: How an Ancient Immune Molecule Could Revolutionize Cancer Immunotherapy
Public Health & Epidemiology The Invisible Invasion: How Micro- and Nanoplastics Disrupt the Gut-Brain Axis and Accelerate Neurodegeneration
Healthcare Quality & Safety Raising the Bar: Multi-Center Study Validates Vietnam’s National Outpatient Satisfaction Framework
Toxicology & Pharmacology Healing the Night: Landmark Clinical Trial Reveals THC Shows Promising Results in Alleviating Severe PTSD Nightmares
Healthcare News & Policy Breathing Hazards: New Study Links Fine Particulate Air Pollution to Severe Rheumatoid Arthritis Flares
Clinical Trials & Research Summit Therapeutics Expands Global Oncology Footprint with Phase II/III HARMONi-GU1 Trial of Ivonescimab in Advanced Urothelial Carcinoma

Archive

Tag: alarming